Client develops therapeutics to treat multi-drug resistant bacterial infections.
Medicare payment for inpatient antibiotics. Education and advocacy regarding continued appropriations for antibacterial funding initiatives. General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Food and Drug Administration legislative and regulatory issues. Advocated to include market incentives for antimicrobials in H.R. 2430 / S. 934 - FDA Reauthorization Act of 2017.
MMM - Medicare/Medicaid BUD - Budget/Appropriations HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL BARRETT THORNHILL JOHN MCMANUS